Abstract
Because tricyclic antidepressants (TAD) are usually given chronically to patients, both their acute and their chronic effects on 5-hydroxytryptamine (5-HT) metabolism were studied. The probenecid method was used and, in addition to 5-hydroxyindoleacetic acid (5-HIAA), some other indole compounds in brain were measured. Simultaneously, TAD levels in brain and plasma were determined. Dimethylated as well as monomethylated TADs were administered, both at 10 and 25 mg/kg i.p.
Treatment with either 10 mg/kg during 14 days or 25 mg/kg given acutely resulted in a similar brain level of TAD, so any differences found could be attributed to differences in administration schedule. Drug levels in brain and plasma differed considerably after chronic and acute treatments but no major differences in the effect on 5-HIAA level in the brain were found, although accumulation of 5-HIAA following probenecid treatment was mostly lowered after treatment with dimethylated TAD. The TAD level in rat brain was not decisive for the effect on central 5-HT turnover. The monomethylated TAD affected the 5-HT turnover very little, not only acutely but also chronically.
Similar content being viewed by others
References
Alpers, H. S., Himwich, H. E.: The effects of chronic imipramine administration on rat brain levels of serotonin, 5-hydroxyindoleacetic acid, norepinephrine and dopamine. J. Pharmacol. Exp. Ther. 180, 531–537 (1972)
Åsberg, M., Bertilsson, L., Tuck, D., Cronholm, B. Sjöqvist, F.: Indolamine metabolism in the cerebrospinal fluid of depressed patients before and during treatment with nortriptyline. Clin. Pharmacol. Ther. 14, 277–286 (1974)
Åsberg, M., Cronholm, B., Sjöqvist, F., Tuck, D.: Relationship between plasma level and therapeutic effect of nortriptyline. Br. Med. J. 1971 III, 331–334
Åsberg, M., Thorén, P., Träskman, L., Bertilsson, L., Ringberger, V.: “Serotonin depression” — a biochemical subgroup within the affective disorders?. Science 191, 478–480 (1976)
Atack, C. V., Lindqvist, M.: Conjoint and native orthophthaldialdehyde-condensate assays for the fluorimetric determinations of 5-hydroxyindoles in brain. Naunyn Schmiedebergs. Arch. Pharmakol. 279, 267–284 (1973)
Bickel, M. H., Weder, H. J.: The total fate of a drug: kinetics of distribution, excretion, and formation of 14 metabolites in rats treated with imipramine. Arch. Int. Pharmacodyn. 173, 433–463 (1968)
Bowers, M. B.: Lumbar CSF 5-hydroxyindoleacetic acid and homovanillic acid in affective syndromes. J. Nerv. Ment. Dis. 155, 325–330 (1974)
Braithwaite, R. A., Goulding, R., Bailey, J., Coppen, A.: Plasma concentration of amitriptyline and clinical response. Lancet 1972 I, 1297–1300
Bruinvels, J.: Inhibition of the biosynthesis of 5-hydroxytryptamine in rat brain by imipramine. Eur. J. Pharmacol. 20, 231–237 (1972)
Burrows, G. D., Davies, B., Scoggins, B. A.: Plasma concentrations of nortriptyline and clinical response in depressive illness. Lancet 1972 II, 619–623 (1972)
Carlsson, A., Corrodi, H., Fuxe, K., Hökfelt, T.: Effect of antidepressant drugs on the depletion of intraneuronal brain 5-hydroxytryptamine-stores caused by 4-methyl-α-ethyl-meta-tyramine. Eur. J. Pharmacol. 5, 357–366 (1969a)
Carlsson, A., Corrodi, H., Fuxe, K., Hökfelt, T.: Effects of some antidepresant drugs on the depletion of intraneuronal brain catecholamine-stores caused by 4-α-dimethyl-meta-tyramine. Eur. J. Pharmacol. 5, 367–373 (1969b)
Corrodi, H., Fuxe, K.: The effect of imipramine on central monoamine neurons. J. Pharm. Pharmacol. 20, 230–231 (1968)
Dingell, J. V., Sulser, F., Gillette, J. R.: Species differences in the metabolism of imipramine and desmethylimipramine (DMI). J. Pharmacol. Exp. Ther. 134, 14–22 (1964)
Friedman, E. Shopsin, B., Goldstein, M. Gershon, S.: Interactions of imipramine and synthesis inhibitors on biogenic amines. J. Pharm. Pharmacol. 26, 995–996 (1974)
Glassman, A. H., Platman, S. R.: Potentiation of a monoamine oxidase inhibitor by tryptophan. J. Psychiatr. Res. 7, 83–88 (1969)
Jori, A., Bernardi, D., Muscettola, G., Garattini, S.: Brain levels of imipramine and desipramine after combined treatment with these drugs in rats. Eur. J. Pharmacol. 15, 85–90 (1971)
Knott, P. J., Curzon, G.: Free tryptophan in plasma and brain tryptophan metabolism. Nature 239, 452–453 (1972)
Leonard, B. E., Kafoe, W. F.: A comparison of the acute and chronic effects of four antidepressant drugs on the turnover of serotonin, dopamin, and noradrenaline in the rat brain. Biochem. Pharmacol. 25, 1939–1942 (1976)
Lidbrink, P., Jonsson, G., Fuxe, K.: The effect of imipamine-like drugs and antihistamine drugs on uptake mechanisms in the central noradrenaline and 5-hydroxytryptamine neurons. Neuropharmacol. 10, 521–536 (1971)
Lyle, W. H., Brooks, P. W., Early, D. F., Leggett, W. P., Silverman, G., Braithwaite, R. A., Cuthill, J. M., Goulding, R., Pearson, I. B., Snaith, R. P.: Plasma concentration of nortriptyline as a guide to treatment. Postgrad. Med. J. 50, 282–287 (1974)
Meek, J., Krall, A. R., Lipton, M. A.: Psychotropic drugs and the metabolism of intracerebrally injected tryptamine, 5-hydroxytryptamine and norepinephrine. J. Neurochem. 17, 1627–1635 (1970)
Meek, J., Werdinius, B.: 5-Hydroxytryptamine turnover decreased by the antidepressant drug chlorimipramine. J. Pharm. Pharmacol. 22, 141–143 (1970)
Modigh, K.: Effect of chlorimipramine on the rate of tryptophan hydroxylation in the intact and transected spinal cord. J. Pharm. Pharmacol. 926–928 (1973)
Moody, J. P., Whyte, S. F., Naylor, G. J.: A simple method for the determination of protriptyline in plasma. Clin. Chim. Acta. 43, 355–359 (1973)
Nagy, A.: Blood and brain concentrations of imipramine and clomipramine and their monomethylated metabolites after oral and intramuscular administration in rats. J. Pharm. Pharmacol. 29, 104–107 (1977)
Neff, N. H., Tozer, T. N., Brodie, B. B.: Application of steady state kinetics to studies of the transfer of 5-hydroxyindoleacetic acid from brain to plasma. J. Pharm. Exp. Ther. 158, 214–218 (1967)
Nybäck, H. V., Walters, J. R., Aghajanian, G. K., Roth, R.: Tricyclic antidepressants: effects on the firing rate of brain noradrenergic neurons. Eur. J. Pharmacol. 32, 302–312 (1975)
Olivier-Martin, R., Marzin, D., Buschenschutz, E., Pichot, P., Boissier, J.: Concentrations plasmatiques de l'imipramine et de la desméthylimipramine et effect anti-dépresseur au cours d'un traitement contrôlé. Psychopharmacologia (Berl.) 41, 187–195 (1975)
Papeschi, R., McClure, D. J.: Homovanillic acid and 5-hydroxy-indoleacetic acid in cerebrospinal fluid of depressed patients. Arch. Gen. Psychiatry 25, 354–358 (1971)
Post, R. M., Goodwin, F. K.: Effects of amitriptyline and imipramine on amine metabolites in the cerebrospinal fluid of depressed patients. Arch. Gen. Psychiatry 30, 234–239 (1974)
Riva, E., Hrdina, P. O., Morselli, P. C.: Measurement of desimipramine in brain tissue by a radioisotope derivative technique. J. Pharm. Pharmacol. 27, 797–799 (1975)
Roffler-Tarlov, S.: Differences between the effects of acute and long-term treatment with desmethylimipramine on reserpine-induced release of amines from rat brain. Biochem. Pharmacol. 24, 1321–1324 (1975)
Ross, S. B., Renyi, A. L.: Tricyclic antidepressant agents. I. Comparison of the inhibition of the uptake of 3H-noradrenaline and 14C-5-hydroxytryptamine in slices and crude synaptosomes preparations of the midbrain-hypothalamus region, of the rat brain. Acta Pharmacol. Toxicol. 36, 382–394 (1975)
Schildkraut, J. J., Winokur A., Applegate, G. W.: Norepinephrine turnover and metabolism in rat brain after long-term administration of imipramine. Science 168, 867–869 (1970)
Schubert, J., Nybäck, H., Sedvall, G.: Effect of antidepressant drugs on accumulation and disappearance of monoamines formed in vivo from labelled precursors in mouse brain. J. Pharm. Pharmacol. 22, 136–139 (1970)
Sheard, M. H., Zolovick, A., Aghajanian, G. K.: Raphe neurons: effect of tricyclic antidepressant drugs. Brain Res. 43, 690–693 (1973)
Tagliamonte, A., Tagliamonte, P., Perez-Cruet, J., Stern, S., Gessa, J. L.: Effect of psychotropic drugs on tryptophan concentration in the rat brain. J. Pharm. Exp. Ther. 177, 475–480 (1971)
Wålinder, J., Skott, A., Carlsson, A., Nagy, A., Roos, B.-E.: Potentiation of the antidepressant action of clomipramine by tryptophan. Arch. Gen. Psychiatry 33, 1384–1389 (1976)
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Van Wijk, M., Meisch, JJ. & Korf, J. Metabolism of 5-hydroxytryptamine and levels of tricyclic antidepressant drugs in rat brain after acute and chronic treatment. Psychopharmacology 55, 217–223 (1977). https://doi.org/10.1007/BF00497851
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00497851